Can Parents Sue If Their Kid Is Born With the 'Wrong' DNA?
By Kristen V. Brown,
Gizmodo
| 04. 18. 2017
It’s a nightmare scenario straight out of a primetime drama: a child-seeking couple visits a fertility clinic to try their luck with in-vitro fertilization, only to wind up accidentally impregnated by the wrong sperm.
In a fascinating legal case out of Singapore, the country’s Supreme Court ruled that this situation doesn’t just constitute medical malpractice. The fertility clinic, the court recently ruled, must pay the parents 30% of upkeep costs for the child for a loss of ‘genetic affinity.’ In other words, the clinic must pay the parents’ child support not only because they made a terrible medical mistake, but because the child didn’t wind up with the right genes.
At a time when rapidly advancing science and technology puts things like genetically engineering embryos to prevent disease in the realm of reality, the case sets an intriguing precedent. First, it places a monetary value on the amount of DNA that a child shares with their parents. And it suggests that the base genetic makeup of a child can actually be ‘wrong.’
“It’s suggesting that the child...
Related Articles
By Jan Grue, The Guardian | 10.27.2026
For a very long time, I dreamed of being cured. I was born in 1981. I learned to walk early enough, but I stumbled and fell more easily than other children. My parents began to worry that something was wrong...
By staff, We Are Egg Donors | 10.21.2026
Michelle Lambrechts is a police officer and one-time egg donor in Belgium. She is also the founder of Ik Zit Met Een Ei, a Belgian nonprofit that advocates for egg donors. (The name is a Dutch play on words...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...